Company Active LTD

Company profile

Viridian Pharma Limited

UK company 04398894, incorporated on 20 March 2002.

Viridian Pharma Limited is a UK company with status Active founded in 2002 based in London.

Company number
04398894
Incorporated
20 Mar 2002
Companies House status
Active

Company identity

Founded / incorporated
20 March 2002

Company number 04398894

Verify at Companies House
Legal name
VIRIDIAN PHARMA LIMITED
Company type
Private Limited Company
Region
London
Registered address
MARTINDALE PHARMA BAMPTON ROAD
HAROLD HILL
ROMFORD
ESSEX
ENGLAND
RM3 8UG
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

1 level 1 ultimate controller
1
Company Active LTD
Viridian Pharma Limited
CRN 04398894
2
Direct and ultimate controller Active LTD
Orphea Limited
CRN 10113308

Company events

Reference milestones and recent Companies House filing stream events.

6 events
08 Nov
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

21 Aug
2026

Accounts With Accounts Type Full

Accounts PDF pending

AA | Transaction MzUzOTg5NjU0MGFkaXF6a2N4 | Paper/PDF filed

Published 21 Aug 2026 22:57

25 Oct
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

20 Mar
2002

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2014
Funded years
2014
Age at first award
11 years

Projects

2014 Feasibility Studies Lead participant

Development of a novel membrane coating technology for the formulation of orally disintegrating tablets to deliver flucloxacillin

1 Feb 2014 to 30 Nov 2014

Awarded
£42,452
Total cost £56,602

Traditionally there has been a reluctance in the pharmaceutical industry to carry out clinical trials in children at the time of licensing. This has led to the scenario where many medicines are not specifically designed for use in children, which can result in poor effectiveness. To address this issue, the European Medicines Agency has recently issued a p...

Product types

Feasibility Studies